ReviewGlomerular diseases

Review of the Role of Rituximab in the Management of Adult Minimal Change Disease and Immune-Mediated Focal and Segmental Glomerulosclerosis.

Ahsan Aslam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.